About the Lab

The Regenerative Neurosurgery and Neuro-Oncology Lab of Terry C. Burns, M.D., Ph.D., serves as a translational hub for neuroregenerative therapies across Mayo Clinic. In collaboration with colleagues at multiple institutions across the country and internationally, Dr. Burns' goal is to expedite the development, rigorous evaluation and translation of safe and effective regenerative therapies for ischemic, traumatic, degenerative and neoplastic diseases of the central nervous system.

Applying neuroregenerative research across neurological disorders

Many mechanisms of DNA damage, senescence, neuroinflammation and altered stem cell function are common to brain tumors, neurodegeneration and central nervous system injury. Therefore, the Mayo Clinic Regenerative Neurosurgery and Neuro-Oncology Lab takes a broad approach to neuroregenerative research, focusing on commonalities that may improve quality of life for patients with a range of neurological disorders.

For example, in the effort to stop tumor cell proliferation, treatments for brain tumors often induce further DNA damage and inflammation, impeding cognitive outcomes in patients who undergo long-term whole-brain radiation. The Regenerative Neurosurgery and Neuro-Oncology Lab is focused on developing and translating regenerative therapies that improve innate defenses against brain tumors, degenerative processes and neurological injuries, thereby improving neurological function and quality of life.

Focusing on cures for humans, not mice

At present, most therapies are developed and tested in mice prior to human clinical trials. Unfortunately, the hundreds of promising therapies developed and tested in rodent models of Alzheimer's disease, stroke, traumatic brain injury and spinal cord injury, among others, have failed when ultimately tested in human clinical trials.

Dr. Burns' recent work indicates that the molecular mechanisms underlying mouse models of neurological disease may be profoundly different from those of human patients. Neurosurgical access to the human brain provides a critical window into mechanisms of human disease that can help tailor ongoing efforts toward treatment of neurological disease in humans, rather than mice.

Dr. Burns is working with an interdisciplinary team of scientists, engineers and clinicians to collaboratively develop an integrated neuroregenerative pipeline focused specifically on human patients with neurological diseases.

View Dr. Burns' biography to learn more about his background and research interests.

Lab members